1
|
Farhat H, Alinier G, Bajow N, Batt A, Helou MC, Campbell C, Shin H, Mortelmans L, Dehghani A, Dumbeck C, Mugavero R, Abougalala W, Zelfani S, Laughton J, Ciottone G, Dhiab MB. Preparedness and Response Strategies for Chemical, Biological, Radiological, and Nuclear Incidents in the Middle East and North Africa: An Artificial Intelligence-Enhanced Delphi Approach. Disaster Med Public Health Prep 2024; 18:e244. [PMID: 39473368 DOI: 10.1017/dmp.2024.160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2025]
Abstract
OBJECTIVE Chemical, biological, radiological, and nuclear (CBRN) incidents require meticulous preparedness, particularly in the Middle East and North Africa (MENA) region. This study evaluated CBRN response operational flowcharts, tabletop training scenarios methods, and a health sector preparedness assessment tool specific to the MENA region. METHODS An online Delphi survey engaging international disaster medicine experts was conducted. Content validity indices (CVIs) were used to validate the items. Consensus metrics, including interquartile ranges (IQRs) and Kendall's W coefficient, were utilized to assess the panelists' agreement levels. Advanced artificial intelligence computing methods, including sentiment analysis and machine-learning methods (t-distributed stochastic neighbor embedding [t-SNE] and k-means), were used to cluster the consensus data. RESULTS Forty experts participated in this study. The item-level CVIs for the CBRN response flowcharts, preparedness assessment tool, and tabletop scenarios were 0.96, 0.85, and 0.84, respectively, indicating strong content validity. Consensus analysis demonstrated an IQR of 0 for most items and a strong Kendall's W coefficient, indicating a high level of agreement among the panelists. The t-SNE and k-means identified four clusters with greater European response engagement. CONCLUSIONS This study validated essential CBRN preparedness and response tools using broad expert consensus, demonstrating their applicability across different geographic areas.
Collapse
Affiliation(s)
- Hassan Farhat
- Ambulance Service, Hamad Medical Corporation, Doha, Qatar
- Faculty of Medicine "Ibn El Jazzar," University of Sousse, Sousse, Tunisia
- Faculty of Sciences, University of Sfax, Sfax, Tunisia
| | - Guillaume Alinier
- Ambulance Service, Hamad Medical Corporation, Doha, Qatar
- School of Health and Social Work, University of Hertfordshire, Hatfield, UK
- Weill Cornell Medicine-Qatar, Doha, Qatar
- Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK
| | - Nidaa Bajow
- Security Forces Hospital, Riyadh, Saudi Arabia
| | - Alan Batt
- Queen's University, Ontario, Canada
- Monash University, Melbourne, Australia
| | - Mariana Charbel Helou
- School of Medicine, Lebanese American University, Beirut, Lebanon
- Lebanese American University-Rizk Hospital, Beirut, Lebanon
| | - Craig Campbell
- School of Paramedicine, University of Tasmania, Tasmania, Australia
| | - Heejun Shin
- Soonchunhyang Disaster Medicine Center, Seoul, South Korea
- Soonchunhyang University Bucheon Hospital, Seoul, South Korea
- Shin's Disaster Medicine Academy, Seoul, South Korea
- Harvard Medical School, Harvard University, Boston, MA, USA
| | - Luc Mortelmans
- European Society for Emergency Medicine, Antwerp, Belgium
- Catholic University of Leuven, Leuven, Belgium
- Free University Brussels, Brussels, Belgium
| | - Arezoo Dehghani
- Safety Promotion and Injury Prevention Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Health in Disasters and Emergencies Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | | | - Roberto Mugavero
- University of Rome "Tor Vergata," Department of Electronic Engineering, Rome, Italy
- University of the Republic of San Marino, Centre for Security Studies
- Observatory on Security and CBRNe Defense, Rome, Italy
| | | | - Saida Zelfani
- SAMU 01 North East, Ministry of Health, Tunis, Tunisia
- Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia
| | - James Laughton
- Ambulance Service, Hamad Medical Corporation, Doha, Qatar
| | - Gregory Ciottone
- Harvard Medical School, Harvard University, Boston, MA, USA
- Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | | |
Collapse
|
2
|
Zhang Y, Liu F, Li XQ, Gao Y, Li KC, Zhang QH. Retention time dataset for heterogeneous molecules in reversed-phase liquid chromatography. Sci Data 2024; 11:946. [PMID: 39209861 PMCID: PMC11362277 DOI: 10.1038/s41597-024-03780-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2024] [Accepted: 08/14/2024] [Indexed: 09/04/2024] Open
Abstract
Quantitative structure-property relationships have been extensively studied in the field of predicting retention times in liquid chromatography (LC). However, making transferable predictions is inherently complex because retention times are influenced by both the structure of the molecule and the chromatographic method used. Despite decades of development and numerous published machine learning models, the practical application of predicting small molecule retention time remains limited. The resulting models are typically limited to specific chromatographic conditions and the molecules used in their training and evaluation. Here, we have developed a comprehensive dataset comprising over 10,000 experimental retention times. These times were derived from 30 different reversed-phase liquid chromatography methods and pertain to a collection of 343 small molecules representing a wide range of chemical structures. These chromatographic methods encompass common LC setups for studying the retention behavior of small molecules. They offer a wide range of examples for modeling retention time with different LC setups.
Collapse
Affiliation(s)
- Yan Zhang
- Key Laboratory of Groundwater Conservation of MWR, China University of Geosciences, Beijing, 100083, People's Republic of China
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Fei Liu
- Key Laboratory of Groundwater Conservation of MWR, China University of Geosciences, Beijing, 100083, People's Republic of China.
| | - Xiu Qin Li
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Yan Gao
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Kang Cong Li
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Qing He Zhang
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China.
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China.
| |
Collapse
|
3
|
Sokolski M, Trenson S, Reszka K, Urban S, Sokolska JM, Biering-Sørensen T, Højbjerg Lassen MC, Skaarup KG, Basic C, Mandalenakis Z, Ablasser K, Rainer PP, Wallner M, Rossi VA, Lilliu M, Loncar G, Cakmak HA, Ruschitzka F, Flammer AJ. Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry. Cardiol J 2024; 31:512-521. [PMID: 38832553 PMCID: PMC11374323 DOI: 10.5603/cj.98489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2023] [Accepted: 04/10/2024] [Indexed: 06/05/2024] Open
Abstract
IMTRODUCTION The high-risk population of patients with cardiovascular (CV) disease or risk factors (RF) suffering from COVID-19 is heterogeneous. Several predictors for impaired prognosis have been identified. However, with machine learning (ML) approaches, certain phenotypes may be confined to classify the affected population and to predict outcome. This study aimed to phenotype patients using unsupervised ML technique within the International Postgraduate Course Heart Failure Registry for patients hospitalized with COVID-19 and Cardiovascular disease and/or RF (PCHF-COVICAV). MATERIAL AND METHODS Patients from the eight centres with follow-up data available from the PCHF-COVICAV registry were included in this ML analysis (K-medoids algorithm). RESULTS Out of 617 patients included into the prospective part of the registry, 458 [median age: 76 (IQR:65-84) years, 55% male] were analyzed and 46 baseline variables, including demographics, clinical status, comorbidities and biochemical characteristics were incorporated into the ML. Three clusters were extracted by this ML method. Cluster 1 (n = 181) represents mainly women with the least number of overall comorbidities and cardiovascular RF. Cluster 2 (n = 227) is characterized mainly by men with non-CV conditions and less severe symptoms of infection. Cluster 3 (n=50) mainly represents men with the highest prevalence of cardiac comorbidities and RF, more extensive inflammation and organ dysfunction with the highest 6-month all-cause mortality risk. CONCLUSIONS The ML process has identified three important clinical clusters from hospitalized COVID-19 CV and/or RF patients. The cluster of males with severe CV disease, particularly HF, and multiple RF presenting with increased inflammation had a particularly poor outcome.
Collapse
Affiliation(s)
- Mateusz Sokolski
- Wroclaw Medical University, Faculty of Medicine, Institute of Heart Diseases, Wroclaw, Poland and Intitute of Heart Diseases, University Hospital, Wroclaw, Poland.
| | - Sander Trenson
- Department of Cardiology, Sint-Jan Hospital Bruges, Bruges, Belgium
| | - Konrad Reszka
- Wroclaw Medical University, Faculty of Medicine, Institute of Heart Diseases, Wroclaw, Poland and Intitute of Heart Diseases, University Hospital, Wroclaw, Poland
| | - Szymon Urban
- Wroclaw Medical University, Faculty of Medicine, Institute of Heart Diseases, Wroclaw, Poland and Intitute of Heart Diseases, University Hospital, Wroclaw, Poland
| | - Justyna M Sokolska
- Wroclaw Medical University, Faculty of Medicine, Institute of Heart Diseases, Wroclaw, Poland and Intitute of Heart Diseases, University Hospital, Wroclaw, Poland
| | - Tor Biering-Sørensen
- Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte, Copenhagen, Denmark
| | - Mats C Højbjerg Lassen
- Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte, Copenhagen, Denmark
| | | | - Carmen Basic
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Zacharias Mandalenakis
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | | | - Peter P Rainer
- Division of Cardiology, Medical University of Graz, Austria
| | - Markus Wallner
- Division of Cardiology, Medical University of Graz, Austria
- Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, United States
- Center for Biomarker Research in Medicine, CBmed GmbH, Graz, Austria
| | - Valentina A Rossi
- Department of Cardiology, University Heart Center, University Hospital, Zurich, Switzerland
| | - Marzia Lilliu
- Division of Infectious Diseases, Azienda ULSS 9, M. Magalini Hospital, Villafranca di Verona, Verona, Italy
| | - Goran Loncar
- Institute for Cardiovascular Diseases Dedinje, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Huseyin A Cakmak
- Department of Cardiology, Mustafakemalpasa State Hospital, Bursa, Türkiye
| | - Frank Ruschitzka
- Department of Cardiology, University Heart Center, University Hospital, Zurich, Switzerland
| | - Andreas J Flammer
- Department of Cardiology, University Heart Center, University Hospital, Zurich, Switzerland
| |
Collapse
|
4
|
Zhang Y, Liu F, Li XQ, Gao Y, Li KC, Zhang QH. Generic and accurate prediction of retention times in liquid chromatography by post-projection calibration. Commun Chem 2024; 7:54. [PMID: 38459241 PMCID: PMC10923921 DOI: 10.1038/s42004-024-01135-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2023] [Accepted: 02/21/2024] [Indexed: 03/10/2024] Open
Abstract
Retention time predictions from molecule structures in liquid chromatography (LC) are increasingly used in MS-based targeted and untargeted analyses, providing supplementary evidence for molecule annotation and reducing experimental measurements. Nevertheless, different LC setups (e.g., differences in gradient, column, and/or mobile phase) give rise to many prediction models that can only accurately predict retention times for a specific chromatographic method (CM). Here, a generic and accurate method is present to predict retention times across different CMs, by introducing the concept of post-projection calibration. This concept builds on the direct projections of retention times between different CMs and uses 35 external calibrants to eliminate the impact of LC setups on projection accuracy. Results showed that post-projection calibration consistently achieved a median projection error below 3.2% of the elution time. The ranking results of putative candidates reached similar levels among different CMs. This work opens up broad possibilities for coordinating retention times between different laboratories and developing extensive retention databases.
Collapse
Affiliation(s)
- Yan Zhang
- Key Laboratory of Groundwater Conservation of MWR, China University of Geosciences, Beijing, 100083, People's Republic of China
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Fei Liu
- Key Laboratory of Groundwater Conservation of MWR, China University of Geosciences, Beijing, 100083, People's Republic of China.
| | - Xiu Qin Li
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Yan Gao
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Kang Cong Li
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China
| | - Qing He Zhang
- Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, People's Republic of China.
- Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation, Beijing, 100029, China.
| |
Collapse
|
5
|
Ait Bennacer S, Aaroud A, Sabiri K, Rguibi MA, Cherradi B. Design and implementation of a New Blockchain-based digital health passport: A Moroccan case study. INFORMATICS IN MEDICINE UNLOCKED 2022; 35:101125. [PMID: 36345287 PMCID: PMC9630302 DOI: 10.1016/j.imu.2022.101125] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Revised: 10/31/2022] [Accepted: 11/01/2022] [Indexed: 11/06/2022] Open
Abstract
In the context of COVID-19 pandemic, the Moroccan Interior and Health Ministries have proposed to use the health pass with a QR code to identify vaccinated people. Additionally, the government suggested a mobile application to control the health passport authenticity. However, the key problem is the possibility of anyone scanning the QR code and figuring out citizens' private information, causing severe issues about individual privacy. In this work, the main contribution is integrating a private Blockchain-based digital health passport to ensure high protection of sensitive information, security and privacy among all the actors (Government, Ministry of Interior, Ministry of Health, verifiers) that comply with the CNDP (National Commission for the Control of Personal Data Protection) and the Moroccan Law 09–08. In our proposed architectural framework solution, we identify two types of actors: authorized and unauthorized, to limit and control access to the citizens' personal information. Besides, to preserve individuals' privacy, we adopt on-chain and off-chain storage (Interplanetary File Systems IPFS). In our case, smart contracts improve security and privacy in the health passport verification process. Our system implementation describes the proposed solution to grant individual privacy. To verify and validate our approach, we used Remix-IDE and Ethereum Blockchain to build smart contracts.
Collapse
|
6
|
Frontera JA, Thorpe LE, Simon NM, de Havenon A, Yaghi S, Sabadia SB, Yang D, Lewis A, Melmed K, Balcer LJ, Wisniewski T, Galetta SL. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study. PLoS One 2022; 17:e0275274. [PMID: 36174032 PMCID: PMC9521913 DOI: 10.1371/journal.pone.0275274] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2022] [Accepted: 09/13/2022] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Post-acute sequelae of COVID-19 (PASC) includes a heterogeneous group of patients with variable symptomatology, who may respond to different therapeutic interventions. Identifying phenotypes of PASC and therapeutic strategies for different subgroups would be a major step forward in management. METHODS In a prospective cohort study of patients hospitalized with COVID-19, 12-month symptoms and quantitative outcome metrics were collected. Unsupervised hierarchical cluster analyses were performed to identify patients with: (1) similar symptoms lasting ≥4 weeks after acute SARS-CoV-2 infection, and (2) similar therapeutic interventions. Logistic regression analyses were used to evaluate the association of these symptom and therapy clusters with quantitative 12-month outcome metrics (modified Rankin Scale, Barthel Index, NIH NeuroQoL). RESULTS Among 242 patients, 122 (50%) reported ≥1 PASC symptom (median 3, IQR 1-5) lasting a median of 12-months (range 1-15) post-COVID diagnosis. Cluster analysis generated three symptom groups: Cluster1 had few symptoms (most commonly headache); Cluster2 had many symptoms including high levels of anxiety and depression; and Cluster3 primarily included shortness of breath, headache and cognitive symptoms. Cluster1 received few therapeutic interventions (OR 2.6, 95% CI 1.1-5.9), Cluster2 received several interventions, including antidepressants, anti-anxiety medications and psychological therapy (OR 15.7, 95% CI 4.1-59.7) and Cluster3 primarily received physical and occupational therapy (OR 3.1, 95%CI 1.3-7.1). The most severely affected patients (Symptom Cluster 2) had higher rates of disability (worse modified Rankin scores), worse NeuroQoL measures of anxiety, depression, fatigue and sleep disorder, and a higher number of stressors (all P<0.05). 100% of those who received a treatment strategy that included psychiatric therapies reported symptom improvement, compared to 97% who received primarily physical/occupational therapy, and 83% who received few interventions (P = 0.042). CONCLUSIONS We identified three clinically relevant PASC symptom-based phenotypes, which received different therapeutic interventions with varying response rates. These data may be helpful in tailoring individual treatment programs.
Collapse
Affiliation(s)
- Jennifer A. Frontera
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Lorna E. Thorpe
- Department of Population Health, New York University, New York, New York, United States of America
| | - Naomi M. Simon
- Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Adam de Havenon
- Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, United States of America
| | - Shadi Yaghi
- Department of Neurology, Brown University School of Medicine, Providence, Rhode Island, United States of America
| | - Sakinah B. Sabadia
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Dixon Yang
- Department of Neurology, New York Presbyterian, Columbia Medical Center, New York, New York, United States of America
| | - Ariane Lewis
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Kara Melmed
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Laura J. Balcer
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
- Department of Ophthalmology, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Thomas Wisniewski
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
- Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America
| | - Steven L. Galetta
- Department of Neurology, New York University Grossman School of Medicine, New York, New York, United States of America
- Department of Ophthalmology, New York University Grossman School of Medicine, New York, New York, United States of America
| |
Collapse
|